Glioblastoma is a fast-spreading form of brain cancer that requires a comprehensive treatment approach. Many patients will receive a combination of surgery, radiation therapy and chemotherapy. Another treatment option that has been shown to help patients with glioblastoma is immunotherapy. Immunotherapy works with your body to encourage your immune system to recognize, target and destroy cancer cells. It’s a promising therapy that is especially beneficial for patients with recurrent or advanced glioblastoma.
Moffitt’s approach to glioblastoma immunotherapy
The Neuro-Oncology Program at Moffitt Cancer Center offers a full spectrum of diagnostics and treatment for patients with glioblastoma. We offer the highest caliber of expertise and take a multispecialty approach with our patients. Our Neuro-Oncology tumor board meets regularly to collaborate and coordinate treatments for our patients, developing individualized plans that meet their unique needs. Our tumor board also discusses current clinical trials—Moffitt has one of the largest clinical trial programs for cancer in the nation—to stay up-to-date on any novel advancements and therapies in brain cancer.
Medically Reviewed by Dr. Michael Vogelbaum, Program Leader, Department of Neuro-Oncology.
Learn more about glioblastoma immunotherapy and our other glioblastoma treatments by scheduling an appointment with the team at Moffitt Cancer Center. You can call us directly at 1-888-663-3488 or submit a new patient registration form online.